Expand Investment in Science and Technology and Empower Industry Development, Legend Holdings Realized Revenue of RMB483.7 billion by 2022

HONG KONG, Mar 31, 2023 - (ACN Newswire via SEAPRWire.com) - Legend Holdings Corporation (stock code: 3396.HK) announced its audited annual results for the year ended December 31, 2022 (the "Reporting Period") on March 31, 2023. During the Reporting Period, Legend Holdings achieved revenue of RMB483.7 billion and net profit attributable to equity holders of the Company of RMB1.167 billion.In 2022, uncertainties in the international situation continued to increase, including rising global inflation and significant volatility in international financial markets and commodity markets, which also had a significant impact on the Company's performance. The industrial incubations and investments segment successfully promoted the listing of over 60 enterprises in the last three years, among the best in the industry. However, as these investments were measured at fair value, the segment's performance was affected by the volatility of the capital market; in addition, Joyvio Group made a provision for goodwill and asset impairment in 2022 year due to factors such as rising operating costs caused by the increase in raw material prices and the interest rate hike by the Federal Reserve. Facing th...

Read More

HTSC announces 2022 annual results, Proposes final dividend of RMB 0.45 per share

HONG KONG, Mar 31, 2023 - (ACN Newswire via SEAPRWire.com) - HTSC (stock code: 6886.HK ; "the Company"), a leading global financial services provider, is pleased to announce the Company's annual results for the year ended December 31, 2022.-- Revenue for the year was RMB 46.82 billion-- Profit attributable to shareholders amounted to RMB 11.05 billion -- Total equity attributable to shareholders of the Company grew 11.23% year-on-year to RMB 165.09 billion. -- The Company proposed a final dividend of RMB 0.45 per shareThe wealth management business reported a revenue of RMB 23.48 billion and continued to account for the majority of the Company's total revenue of 50.15%. Revenues from the institutional services business and investment management business were RMB 8.13 billion and RMB 2.27 billion, accounting for 17.37% and 4.85%, respectively, of the Company's total.The international business segment posted a record revenue of RMB 9.41 billion despite global economic challenges, growing by 19.28% year-on-year and accounting for 20.10% of the Company's total. During the year, the Company was ranked second as a sponsor amongst Chinese securities companies in Hong Kong by amount.HTSC's...

Read More

HTSC reports annual revenue of RMB 46.82 billion in 2022

HONG KONG, Mar 31, 2023 - (ACN Newswire via SEAPRWire.com) - HTSC (stock code: 6886.HK ; "the Company"), a leading global financial services provider, is pleased to announce the Company's annual results for the year ended December 31, 2022.-- Revenue for the year was RMB 46.82 billion-- Profit attributable to shareholders amounted to RMB 11.05 billion -- Total equity attributable to shareholders of the Company grew 11.23% year-on-year to RMB 165.09 billion. -- The Company proposed a final dividend of RMB 0.45 per shareThe wealth management business reported a revenue of RMB 23.48 billion and continued to account for the majority of the Company's total revenue of 50.15%. Revenues from the institutional services business and investment management business were RMB 8.13 billion and RMB 2.27 billion, accounting for 17.37% and 4.85%, respectively, of the Company's total.The international business segment posted a record revenue of RMB 9.41 billion despite global economic challenges, growing by 19.28% year-on-year and accounting for 20.10% of the Company's total. During the year, the Company was ranked second as a sponsor amongst Chinese securities companies in Hong Kong by amount.HTSC's...

Earable Neuroscience and Excelpoint Announces Strategic Partnership to Accelerate the Commercialisation of the World’s First AI-powered Consumer Wearable, FRENZ Brainband, to Solve Global Sleep Pandemic

Since the COVID-19 pandemic began, researchers around the world have documented a surge in sleep disorders which affect overall health, safety and quality of lifeInvented by Earable® Neuroscience, FRENZ™ Brainband is the world's first AI-powered consumer wearable that tracks and stimulates brain activities to enhance mental well-being through improvements in sleep, relaxation and focusWith its leading regional B2B business platform that provides quality electronics components with integrated R&D capabilities, Excelpoint will be the exclusive procurement partner for the electronics components used for the production of FRENZ™ Brainband At the same time, PlanetSpark, the entrepreneurial and strategic investment arm of Excelpoint, is currently exploring its options to make an investment in Earable® NeuroscienceSingapore / Boulder, CO, Mar 31, 2023 - (ACN Newswire via SEAPRWire.com) - Earable® Neuroscience U.S. ("Earable®"), is pleased to announce a strategic partnership with Singapore-based Excelpoint Technology Pte. Ltd., ("Excelpoint") to accelerate the commercialisation of the world's first AI-powered consumer wearable, FRENZ™ Brainband, which tracks and stimulates brain activi...

With Innovation-driven Quality, Sustainable Development, Wuling Motors(00305.HK)Returns to Profitability in 2022

HONG KONG, Mar 31, 2023 - (ACN Newswire via SEAPRWire.com) - As the global new energy automobile industry continues to experience rapid growth, there has been an acceleration in the R&D and application of new products and technologies. Technological innovation is driving the continuous upgrading of the industry. At the same time, the automotive industry is also ushering in a new round of disruptive changes amidst the wave of digitalization and intelligence.Amidst changes in its internal and external environments, Wuling Motors Holdings Limited (the "Company" or "Wuling Motors",Stock Code:00305.HK) has shown remarkable innovation in leading the way toward high-quality development. Today, the Company delivered impressive results for 2022, with annual revenue hitting RMB 12.596 billion (UOM in RMB, same below), effectively transforming losses into profits.Innovation-driven Wuling Motors charts a new growth curve for 2022Technological innovation, industrial upgrading and the continued impact of the pandemic have brought profound and far-reaching systemic changes to the automotive industry. The implementation of the national "dual carbon" strategy has brought about widespread change...

Read More

Seedify Incubates and Launches ChainGPT, an AI Solution for the Crypto and Blockchain Industry

Victoria, Seychelles, March 31, 2023 – (SEAPRWire) – Seedify, a leading launchpad and incubator in the crypto industry, has announced the launch of ChainGPT, an AI model designed to provide solutions and use cases related to crypto and blockchain technology. Seedify has launched over 50 Initial Gaming Offerings (IGOs) and entered the NFT space with an NFT launchpad and marketplace. Early last year, Seedify announced the launch of its incubation program, which takes its initial launchpad offerings one step further, assisting projects even more through sharing best practices around development, funding, tokenomics design, and access to Seedify’s extensive KOLs network and marketing partners. With the community’s strong support for the decision to expand into AI projects, Seedify has been actively seeking out AI projects to work with. ChainGPT’s Initial Dex Offering (IDO) is the first step in its mission to gradually dominate the launchpad space again. ChainGPT offers services such as blockchain analytics, AI trading, smart-contract development, AI auditing, risk management, and more. The AI model was specifically developed to assist with various crypto and blockchain requirements. It...

征程万里风正劲 海通恒信2022年交出亮眼成绩单

HONG KONG, Mar 31, 2023 - (亚太商讯 via SEAPRWire.com) - 目前,中国融资租赁行业正处于统一监管、统一登记、加速出清、转型优化的关键时期,挑战与机遇并存。截至2022年末,全国融资租赁合同余额约58,500亿元,较2021年末下降5.8%,整体上依然处于收缩态势。日前,海通恒信国际融资租赁股份有限公司(以下简称“海通恒信”)发布2022年业绩报告。2022年,海通恒信实现逆势增长,实现收入总额85.25亿元,同比增长4.2%;实现年度盈利15.33亿元,同比增长8.5%。截至2022年末,集团资产总额达1,245.14亿元,较上年末增长8.5%。营收利润双增长 资产质量保持稳定2022年,海通恒信强化企业责任担当,立足大局、主动作为、超前谋划,紧跟国家战略及政策导向,切实立足租赁本源,充分运用金融科技手段,全力保障公司规模与收益的稳健增长。数据显示,截至2022年末,海通恒信资产总额达1,245.14亿元,较上年末增长8.5%;权益总额达188.27亿元,较上年末增长6.9%。2022年,实现收入总额85.25亿元,同比增长4.2%;实现年度盈利15.33亿元,同比增长8.5%;2022年集团生息资产平均收益率为6.81%,加权平均净资产回报率为9.16%。2022年,集团实现融资提款735亿元,其中,通过银团贷款、银行双边贷款及银行承兑汇票等渠道,实现间接融资提款375亿元,占比51%;实现直接融资提款360亿元,占比49%,直接融资渠道主要包括:公司债券、中期票据、短期融资券、超短期融资券、资产支持证券与资产支持票据、境外美元债等融资工具。通过创新融资工具,拓宽融资渠道,集团融资成本有效降低,2022年计息负债平均付息率为3.73%,较上年下降0.20个百分点。资产质量方面,得益于集团通过主动管理资产配置、快速应对化解风险事件、积极探索创新资产处置方式、不断加大资产处置力度等举措,风险防范和处置能力不断增强,资产质量保持稳定。截至2022年末,集团不良资产率为1.09%,不良资产拨备覆盖率为252.02%,不良资产率处于安全可控水平。持续优化资产结构 高质量服务实体经济2022年,海通恒信秉持服务实体经济的宗旨,坚实推进“一体两翼”、“一大一小”发展战略,深耕属地化区域布局,不断优化资产结构,确保资产分布的安全稳健性、发展前瞻性、经营收益性有机统一。从资产投放来看,海通恒信紧跟国家产业政策导向,积极应对宏观环境挑战,著力推动“高端装备制造”、“绿色租赁”、“数字经济”等战略新兴行业优质客户的深度合作。2022年,集团实现业务投放715.74亿元,同比增长7.2%。具体来看,持续加大“专精特新”客户合作力度,相关高端装备制造业务全年投放超140亿元,投放占比近20%;紧抓绿色低碳产业发展契机,大力推动绿色租赁多...

Yunkang Group Announces First Annual Results Since Listing

Revenue increases by 121.4% to RMB 3,756 million Profit attributable to owners of the Company of RMB 377 million Three major businesses grow rapidly through in-depth service and lean management HONG KONG, Mar 31, 2023 - (ACN Newswire) - Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its first annual results for the year ended December 31, 2022 (the "Reporting Period") since its listing. Driven by the promotion of health care policies in mainland China, the Group has made steady progress in service network expansion, operational efficiency improvement and lean management, and achieved quality growth under the annual goals of "in-depth service, lean management and achieving quality growth". In particular, in the field of diagnostic testing services for medical institution alliances, the Group has developed a set of medical institution alliance construction and operation support solutions with the advantages of "professionalism, standardization and intelligence", which effectively enhanced the diagnostic capabilities and service efficiency of medical institution alliances and continued to have a...

阳光保险:打造全新客户战略 全力推进高价值发展

HONG KONG, Mar 31, 2023 - (亚太商讯 via SEAPRWire.com) - 作为国家和社会的稳定器,近年来,中国保险业在补偿灾害损失、维护社会安定、支持中国的经济建设等方面发挥了重要作用。2023年3月29日,中国快速成长的民营保险服务集团——阳光保险集团股份有限公司(「阳光保险」或「公司」,06963.HK)公布截至2022年12月31日止全年业绩。于2022年,阳光保险坚持专注保险主业和价值发展,各业务板块保持了良好的发展态势,总体经营业绩实现稳健增长。全年实现总收入1,285.8亿元,同比增长7.2%。实现归属母公司股东的净利润48.8亿元。总保费收入1,087.4亿元,同比增长6.9%;其中,阳光人寿保费收入683亿元,同比增长12.3%,阳光财险保费收入403.8亿元。深入推进「纵横伙伴」战略落地 有效客户数快速增长二十大报告把「质的有效提升与量的合理增长」作为经济高质量发展的内在要求,阳光保险以此作为公司发展的根本遵循与指引,捍卫价值发展理念。年报数据显示,阳光保险2022年全年实现内含价值1,012.7亿元,增长8.0%。阳光人寿一年新业务价值30.2亿元,同比实现行业内少有的正增长。后期,公司将继续坚持价值发展理念,牵引整体经营能力的稳步提升。近年来,行业整体进入深度调整与转型期,面对的客户需求愈发多元化、差异化,保险供给端也需主动适配客户新需求、聆听客户新声音。在客户经营方面,阳光保险以「纵横伙伴」战略计划为抓手,深入实施面向个人家庭的「纵横」计划,围绕客户健康、养老、子女教育、财富管理等核心需求,构建覆盖家庭全生命周期的多层次、差异化的产品服务生态体系,以及面向企业组织的「伙伴」行动,为企业客户提供系统集成的一揽子风险解决方案,推动阳光从单纯的经济补偿保险提供商向风险管理服务支持商转变,赢得有效客户数快速增长。年报数据显示,截至2022年末,公司有效客户数约3,288万,庞大的用户群体为公司的业绩增长提供有力支撑。全面推进数字化转型和科技创新 积极履行社会责任在聚焦主业的同时,阳光保险全面推进数字化转型和科技创新,推动业务在线化、智能化和公司价值提升。阳光人寿推动数字科技在销售支持、客户服务、风险防范等方面落地应用,赋能业务和运营效能提高;阳光财险借助大数据、人工智能、云计算、物联网等核心技术,赋能服务、销售、理赔、产品、运营、生态圈业务全流程及周边领域。于2022年,公司获得外部各类技术创新奖项14项,当年新增授权专利13项,可以预期,随着数字化转型不断加速,公司的运营效能将持续优化,其高质量发展根基亦将得到进一步夯实。值得一提的是,自成立以来,阳光保险始终不忘初心,积极履行社会责任。年报数据显示,2022年全年,公司为实体经济提供风险保障44.5万亿元,为「一带一路」项目提供风险保障822亿元,为中小微企...

阳光保险上市成绩单首秀:业务彰显强劲韧性 高质量发展行稳致远

HONG KONG, Mar 31, 2023 - (亚太商讯 via SEAPRWire.com) - 3月29日,阳光保险公布上市后的首份成绩单。回顾2022年,中国保险业面临市场营销难度加大、居民消费意愿趋弱、资本市场波动等多因素影响,行业整体承压。保险行业在2022年压力巨大,对此,张维功表示,“阳光保险顺利度过了这一高强度的压力测试。”同时,他还表示通过举措和改革,全公司更进一步树立了客户思想,“客户思想全面提升是2022年阳光最大的进步。”阳光保险聚焦保险主业,持续强化公司的价值发展能力,保持总体经营业绩的稳健增长,彰显出这家企业强劲的经营韧性。整体来看,阳光保险2022年总资产稳中有升,保费收入持续增长。截至2022年末,公司总资产约人民币4,853.6亿元,较年初增加9.9%。实现总收入人民币1,285.8亿元,同比增长7.2%;其中总保费收入人民币1,087.4亿元,同比增长6.9%。实现归母净利润人民币48.8亿元。业务发展呈现较大韧性 价值创造能力持续增强2022年,阳光保险坚持「稳字当头、好字当头」的发展理念,不断优化渠道布局,加速模式创新,保费规模稳定增长,内含价值持续提升,业务结构保持稳定。截至2022年末,公司内含价值约人民币1,012.7亿元,同比增长8.0%,继续保持良好的增长态势。寿险业务方面,阳光人寿坚持价值引领,很早就提出通过渠道多元化协同发展的经营模式,培育自身潜力,并以「多线并举」持续夯实业务发展基础。分渠道来看,代理人渠道加快队伍转型,人均产能进一步提升至1.4万元,同比增长13.9%,MDRT达标人数同比增长31% ;银保渠道以价值发展为核心,大力发展长期期缴价值型业务,趸期比逐年优化。此外,阳光人寿也在持续加快其他渠道发展步伐,优化业务结构。2022年,阳光人寿实现新单期缴保费收入人民币147.5亿元,同比增长9.3%;一年新业务价值人民币30.2亿元,在行业新业务价值承压的大趋势下实现了保险业极其少有的当年新业务价值的正增长。财险业务方面,阳光财险持续深化个人客户与团体客户经营,增强风险管理服务与保障,盈利能力得到快速提升,各险种业务发展全面提速,综合赔付率与综合费用率同比分别下降1.6与3.6个百分点。车险智能生命表运用渐入佳境,非车险风险识别和产品定价能力稳步提升,风险减量管理初见成效。2022年,阳光财险保费收入人民币403.8亿元,实现净利润达16.02亿元。全面推进数字化转型 以科技实力开拓未来增长空间当前,保险业已进入数字化转型的新阶段。阳光保险以流程优化和数据及模型应用为重点,不断提升数字化客户洞察、数字化营销、数字化产品创新、数字化风控、数字化运营五大核心能力,促进公司运营效率和服务质量提升。在客户服务方面,阳光人寿依托「我家阳光」 APP智慧服务平台,为客户提供7*24小时的极致服务体验,...

Read More

Eisai: Additional Detailed Analyses from Phase 2 Study 201 of Lecanemab Published as Three Papers in Peer-Reviewed Journals

TOKYO and CAMBRIDGE, Mass., Mar 31, 2023 - (JCN Newswire via SEAPRWire.com) - Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that three additional detailed analyses from the Phase IIb clinical study (Study 201), evaluating the efficacy and safety of lecanemab for mild cognitive impairment (MCI) due to Alzheimer's disease (AD) and mild AD (collectively known as early AD), were published in the peer-reviewed journals.1. Detailed results on biomarker, cognitive, and clinical effects from Study 201 core to OLE (open-label extension): Alzheimer's Research and Therapy2. Consistency of efficacy results across various clinical measures and statistical methods in Study 201: Alzheimer's Research and Therapy3. ARIA (amyloid-related imaging abnormality) profile in Study 201: Alzheimer's & Dementia: Translational Research and Clinical InterventionsStudy 201 was a multicenter, double-blind, placebo-controlled, Phase 2b trial conducted in 856 patients with early AD. Its core study evaluated key efficacy assessments, including clinical change on the AD Composite Score (ADCOMS) as the primary endpoint at 12 months and as key secondary endpoints, ADCOMS, Clinical Dementia Rating-...

Read More

Osaka Gas and MHI to Collaborate in CO2 Value Chain Development for CCUS

TOKYO, Mar 31, 2023 - (JCN Newswire via SEAPRWire.com) - Osaka Gas Co., Ltd. (Osaka Gas) and Mitsubishi Heavy Industries, Ltd. (MHI) have entered into an agreement to conduct a feasibility study on a project to develop a CO2 value chain for CCUS (Carbon Capture, Utilization, and Storage), including transporting CO2 captured in Japan to overseas, utilizing it to produce e-methane, synthetic gas produced through methanation, and storing it underground.The project aims to establish an efficient CO2 value chain, leveraging Osaka Gas's know-how on e-methane production and CO2 storage and MHI's expertise in CO2 capture, liquefied CO2 maritime vessel transport, and CO2 management.To that end, the project partners will examine methods to capture CO2 emitted from the Hard-to-Abate industries, such as steel, cement, and chemicals, and transport liquefied CO2 using ships. Osaka Gas and MHI will conduct a feasibility study on the entire CCUS scheme, including CO2 utilization for e-methane and underground sequestration, in corporation with companies from a wide variety of industries.The project also plans to expand its CCUS scheme through the trade and transfer of CCUS's environmental value qua...

Read More

Demonstration Test of “Smart Industrial Safety” by Newly Developed MHI Drone Carried Out with Chubu Electric

TOKYO, Mar 31, 2023 - (JCN Newswire via SEAPRWire.com) - Mitsubishi Heavy Industries, Ltd. (MHI), in collaboration with Chubu Electric Power Co., Inc. (Chubu Electric), has conducted a demonstration test of "Smart Industrial Safety," a system that performs on-site confirmation by drone. The test, carried out in Toyota City, Aichi Prefecture, confirmed the effectiveness of security operations performed by a drone currently under development by MHI.Demonstration testing of "Smart Industrial Safety" by MHI droneThe Hydro Power Business Department of Chubu Electric's Renewable Energy Company is currently challenged by a manpower shortage and the need to secure the safety of its employees who perform on-site confirmation at dams and power stations located in mountainous regions that are difficult to access, requiring travel over narrow roads by motor vehicle or on foot. The drone demonstration test was conducted to resolve these challenges and simultaneously achieve greater work efficiency at reduced cost.The drone used in the testing was a single rotor UAV under development in MHI's Commercial Aviation Systems segment. Flying at an altitude of 35-50m at speeds of 10-20kph, the drone's ...

Read More

GF Securities Announced 2022 Annual Results

HONG KONG, Mar 31, 2023 - (ACN Newswire via SEAPRWire.com) - GF Securities Co., Ltd. ("GF Securities" or the "Company", together with its subsidiaries, the "Group"; HKSE: 1776; SZSE: 000776), one of the most influential securities companies in the Chinese capital market, announced its annual results for the twelve months ended 31 December 2022 (the "Reporting Period"). In the face of the complicated internal and external situation, embracing the working philosophy of "making positive changes and promoting the high-quality development of the Company to a new level" and "firmly focus on principal duties and businesses and improve core business", GF Securities continued to maintain a good momentum with its operating performance at the forefront of the industry, realizing a total revenue and other income of RMB33,256 million and a net profit attributable to shareholders of the Company of RMB7,929 million. As of 31 December 2022, the Group's total asset amounted to RMB617,256 million, representing an increase of15.19% compared to the end of 2021.Lin Chuanhui, Chairman and General Manager of GF Securities, said, in 2022, the Company actively explored new business development models and m...

Read More

China Risun’s 2022 Revenue Ups 9.6% to RMB43.1 Billion, Profit Attributable to Owners was RMB1.9 Billion

HONG KONG, Mar 31, 2023 - (ACN Newswire via SEAPRWire.com) - China Risun Group Limited ("China Risun", or the "Group", stock code: 1907), a leading global integrated coke, coking chemicals and refined chemicals producer and supplier and relevant operation management services provider in China, announced today its annual results for the year ended 31 December 2022 ("the reporting year"). The Group continued its expansion in the annual capacity of all the products and its further refining ability to high-end chemicals products. It has also strategically focused on increasing its market share through nationwide distribution and global expansion initiatives. Revenue for the year ended December 31, 2022 was up 9.6% to approximately RMB43.1 billion. Profit attributable to owners of the Company was approximately RMB1.9 billion. Basic earnings per share of the Company was RMB42 cents. To share the fruit of its outstanding results performance, the Board determined to declare a final dividend of RMB0.9 cents per share (equivalent to HK1.0 cents per share).Scale of coke business keeps swelling, Further consolidated industry leadershipDuring the reporting year, the Group expanded its coke prod...

Read More

Wintermar Offshore (WINS:JK) Reports FY2022 Results

JAKARTA, Mar 31, 2023 - (ACN Newswire via SEAPRWire.com) - PT Wintermar Offshore Marine Tbk (WINS:JK) recorded FY2022 gross profit of US$11.2 million, an 88% YOY growth, on the back of rising utilization and charter rates, and a 510%YOY jump in net profit to US$1.1 million. Higher utilization and rising charter rates contributed to a strong operational performance in FY2022 with EBITDA up 28% to US$17.5 million on total revenue of US$61 million (+44%YOY). Owned Vessel DivisionOffshore upstream activity picked up steadily over the course of FY2022 amidst a sustained rise in oil prices and continued tensions in Ukraine. Demand for OSVs, in particular in the higher value vessels, was stronger towards the second half of FY2022, and utilization of Wintermar's fleet reached 83% in 4Q2022 compared to 61% in 1Q2022. In 2022, the Company purchased 6 units of mid to high tier vessels, of which 3 units have commenced operations. Including the 2 units of Platform Supply Vessels (PSV) purchased in December 2021, Wintermar has added a total of 8 vessels to the fleet in the past 18months. At the end of December 2022, there were 4 vessels still undergoing reactivation, comprising 2 units of Platfo...

Read More

Austar Lifesciences Announces 2022 Annual Results

HONG KONG, Mar 31, 2023 - (ACN Newswire via SEAPRWire.com) - Austar Lifesciences Limited ("AUSTAR" or "Company") (HKEX Stock Code: 6118.HK), a technology-based pharmaceutical engineering solution provider, together with its subsidiaries (collectively the "Group" or "AUSTAR Group"), announced its audited annual results for the year ended 31 December 2022 ("Reporting Period"). Although the Group was affected by the requirements for epidemic control causing challenges to its supply chain, manufacturing, and project execution, the Group recorded a growth of approximately 10.6% in revenue as compared to the corresponding period in 2021. Thanks to the Group's capacities to offer modular and innovative solutions with digitalisation and robotic technologies based on excellent containment-based engineering and contamination control practices, the Group's product lines in the sectors of active pharmaceutical ingredients (API) and oral solid dosage (OSD) in chemical drugs have still been recorded a significant growth in order-in-take and revenue.RESULTS OF OPERATIONS BY BUSINESS SEGMENTLiquid and Bioprocess SystemDuring the Reporting Period, through effective management of supply chain and pr...

Read More

Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia

HONG KONG, Mar 31, 2023 - (ACN Newswire via SEAPRWire.com) - On 28th March 2023, Rxilient Biotech (a portfolio company of Legend Capital) and Junshi Biosciences made a joint announcement that two parties will form a joint venture to develop and commercialize toripalimab in Thailand, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, and Vietnam[1].From left to right: CEO of Junshi Biosciences, Dr. Li Ning; Managing Director of Legend Capital, Executive Director of Rxilient, Mr. Hong Tan; Chairman, Chief Executive and President of CMS, Mr. Lam Kong; Chairman of Junshi Biosciences, Mr. Xiong Jun; CEO of Rxilient, Dr. Lee Ker YinToripalimab is an anti-PD-1 monoclonal antibody independently developed by Junshi Biosciences. Junshi Biosciences has conducted over 30 clinical trials globally (in China, the USA, Southeast Asia, and Europe) covering more than 15 indications, including cancers of the lung, nasopharynx, esophagus, stomach, bladder, breast, liver, kidney, and skin. Six of these indications have been approved in China, and multiple marketing applications are currently under review by regulatory agencies in the US, EU, and UK."Cancer patients need toripalimab....

Read More

The Latest Book on Educating the Girl Child in Africa by the Renowned Beauty Queen, Jennifer Ephraim, Has Received Global Acclaim Upon Its Launch

ABUJA, NG, Mar 31, 2023 - (ACN Newswire via SEAPRWire.com) - Queen Jennifer Ephraim, a renowned beauty queen, humanitarian, and fundraising expert, recently launched a highly anticipated book titled "DILEMMA OF THE NIGERIAN GIRL CHILD" on Amazon.com through the Jennifer Ephraim Foundation. The book is aimed at providing innovative solutions to issues faced by the girl child in Africa, such as early marriages, child abuse, and sex trafficking.Jennifer Ephraim Launches New Book "The Dilemma of the Nigerian Girl Child"Unlike traditional fundraising methods like cookie sales and car washes, the book suggests ideas to direct money into classrooms, schools, and districts continuously. It is written in an intelligent and concise manner to save readers' time and keep them up-to-date with the latest fundraising innovations in Africa.Queen Jennifer Ephraim has been involved in humanitarian activities for many years and holds a B.S. degree in International Relations, Project Management, and Human Resource Management. She is available for speaking engagements and can be contacted through her email at jenniferephraim88@gmail.com, Instagram handle @queen_jennifer_ephraim, and her Foundation webs...

Read More

Yunkang Group Announces First Annual Results Since Listing

HONG KONG, Mar 31, 2023 - (ACN Newswire via SEAPRWire.com) - Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its first annual results for the year ended December 31, 2022 (the "Reporting Period") since its listing. Driven by the promotion of health care policies in mainland China, the Group has made steady progress in service network expansion, operational efficiency improvement and lean management, and achieved quality growth under the annual goals of "in-depth service, lean management and achieving quality growth". In particular, in the field of diagnostic testing services for medical institution alliances, the Group has developed a set of medical institution alliance construction and operation support solutions with the advantages of "professionalism, standardization and intelligence", which effectively enhanced the diagnostic capabilities and service efficiency of medical institution alliances and continued to have a positive impact on the Group's profitability. During the Reporting Period, the Group's revenue reached RMB3,756 million, representing a year-on-year increase of 121.4%, and it...